"There is no indication at this stage for anyone to be taking this drug other than the very high-risk groups in areas in which the avian disease has become a problem," he added.
«Ne postoje nagoveštaji da u ovoj fazi bilo ko treba da uzima lek, osim izuzetno rizičnih grupa u onim oblastima u kojima je ptičiji grip postao problem», dodao je on.